Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis

Am J Respir Crit Care Med. 2020 Jun 1;201(11):1449-1450. doi: 10.1164/rccm.202002-0271LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants
  • Double-Blind Method
  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Thrombomodulin*

Substances

  • Anticoagulants
  • Thrombomodulin